Breakthrough Molecular Imaging

Bringing better care & quality of life to patients wherever they are.

Through its wholly owned subsidiaries, Serac Life Sciences is developing two late-stage molecular imagingⓘ technologies to help physicians deliver personalised medicineⓘ to more patients.

Maraciclatide, inflammatory arthritis and endometriosis

Visit Website

Maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities. Images courtesy of Dr Toby Garrood, Guy’s Hospital, London

Seracam Hybrid gamma/optical camera

Visit Website

Seracam (hybrid gamma/optical camera) is for investigational use only and has not been cleared or approved by the FDA or UK and European regulatory authorities.

Team

Discover more about the team behind Serac Life Sciences

Read More

Investors

Developing game-changing molecular imaging technologies

Read More

News

News and press releases on our company and products

Read More